lutetium has been researched along with Thymus Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Das, T; Mishra, KP; Sarma, HD; Venkatesh, M; Vidyasagar, PB | 1 |
| Bakker, WH; de Herder, WW; Krenning, EP; Kwekkeboom, DJ; van Aken, MO; van Essen, M | 1 |
2 other study(ies) available for lutetium and Thymus Neoplasms
| Article | Year |
|---|---|
Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.
Topics: Animals; Female; Fibrosarcoma; Lutetium; Lymphoma; Mice; Neoplasms, Experimental; Porphyrins; Radioisotopes; Radiopharmaceuticals; Thymus Neoplasms; Tissue Distribution | 2011 |
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.
Topics: Adult; Aged; Bronchial Neoplasms; Carcinoid Tumor; Disease Progression; Female; Humans; Lutetium; Male; Medical Oncology; Middle Aged; Octreotide; Peptides; Radioisotopes; Remission Induction; Stomach Neoplasms; Thymus Neoplasms; Treatment Outcome | 2007 |